Evidence mapPaperPMID 38715957Full record

ArticleAnalytical science advances2021

Telmisartan detection by UV spectrophotometry in mice drinking water.

Leidyanne Ferreira Gonçalves, Caroline Fernandes-Santos

Abstract read
In one paragraph

Article in Analytical science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leidyanne Ferreira GonçalvesNúcleo de Estudos em Metabolismo Nutrição e Histopatologia (NEMENUTH) Instituto de Saúde de Nova Friburgo Universidade Federal Fluminense Dr. Silvio Henrique Braune, 22, Centro Nova Friburgo RJ 28.625-650 Brazil.ORCID https://orcid.org/0000-0002-1730-8007
Caroline Fernandes-SantosNúcleo de Estudos em Metabolismo Nutrição e Histopatologia (NEMENUTH) Instituto de Saúde de Nova Friburgo Universidade Federal Fluminense Dr. Silvio Henrique Braune, 22, Centro Nova Friburgo RJ 28.625-650 Brazil.ORCID https://orcid.org/0000-0002-2420-3836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal models are often used to test the safety and efficacy of drugs in cell culture and body systems. Several researchers deliver drugs to rodents in drinking water, although it has some limitations. For instance, drug stability, water consumption, and body mass fluctuation may change drug dose. Thus, we investigated telmisartan (TEL) stability in mice drinking water by UV spectrophotometry, and if water intake and body mass were fluctuated then it changes the predicted drug dose. The results showed that UV spectrophotometry could detect TEL at the wavelength of 300 nm, and the concentration curve was set between 1.25 and 60 µg/mL. Also, it remained stable in mice drinking water for 7 days at the predicted concentration. Mice gained weight after 8 weeks on a high-fat high-sucrose diet, and it was reduced by TEL 5 mg/kg/day after 3 weeks. Although water intake remained stable, not adjusting the TEL concentration weekly by body mass would lead to higher consumption of TEL by mice. In conclusion, we demonstrated that body mass and water intake fluctuations significantly change the amount of drug that the animal receives, which would add bias to the experiment. TEL remains stable for at least 7 days in wrapped mice water bottles in the animal care facility, and UV spectrophotometry proved to be a simple and low-cost method to detect TEL in mice drinking water.

Indexed as

C57Bl/6 micedrinking waterdrug administrationtelmisartanUV spectrophotometry

Identifiers

PMID38715957
PMCPMC10989599

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.